Moleculin Biotech
| Region | Nordamerika |
| ISIN | US60855D1019 |
| Sektor | Biotechnologie |
| Website | http://www.moleculin.com/ |
Moleculin Biotech is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center, the world’s largest cancer research facility headquartered within the world’s largest medical center.
| Titel | Datum |
|---|---|
| AEON, Ajinomoto, Allianz, Avillion, Bank Islam, Elridge Energy, FGV, Gamuda, GDB, Haily, Hextar, HLIND, Ivory Properties, Kerjaya, Magma,... | vor ungefähr 2 Monaten |
| MISC Group Q2 2025 profit falls to USD 97.5 mln | vor ungefähr 2 Monaten |
| MISC's 2Q25 Net Profit Slips 14% To RM464.4 Million On Weaker Engineering And Gas Segments | vor ungefähr 2 Monaten |
| MISC's Net Profit Down 7.1% To RM1.2 Billion On Lower Revenue | vor ungefähr 2 Monaten |
| MISC's 2Q profit down 14% on weaker gas and marine ops, declares eight sen dividend | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Minori Solutions (1 Artikel) | |
| Microsoft (1 Artikel) | |
| Moovly Media (1 Artikel) | |
| MorphoSys (1 Artikel) | |
| Alle anzeigen | |